EPLIN-α and Its Role in Breast Cancer
Author Information
Author(s): Jiang Wen G, Martin Tracey A, Lewis-Russell Jonathan M, Douglas-Jones Anthony, Ye Lin, Mansel Robert E
Primary Institution: Cardiff University School of Medicine
Hypothesis
The study investigates the expression of EPLIN-α in human breast cancer tissues and its impact on cellular migration and clinical outcomes.
Conclusion
EPLIN-α expression is down-regulated in breast cancer cells and tissues, which is linked to poorer prognosis.
Supporting Evidence
- Low levels of EPLIN-α were found in tumor tissues compared to normal tissues.
- Grade-2/3 tumors had significantly lower levels of EPLIN-α compared to grade-1 tumors.
- Patients with poor prognosis had significantly lower levels of EPLIN-α.
- Patients who developed recurrence and died of breast cancer had lower levels of EPLIN-α.
- High levels of EPLIN-α were associated with longer survival.
Takeaway
EPLIN-α is a protein that helps keep breast cancer cells from growing and moving too much, and having less of it means a worse outcome for patients.
Methodology
The study analyzed EPLIN-α expression in tumor and normal tissues, and evaluated cellular migration and growth using various assays.
Participant Demographics
Patients included 120 with breast cancer and 32 with normal mammary tissues.
Statistical Information
P-Value
p = 0.0003, p = 0.0008, p = 0.0081, p = 0.0461, p = 0.0345
Confidence Interval
135.3 (123.6–147.1), 141.7 (138.5–148.7), 129.4 (116.3–142.2), 140 (132.4–147.7)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website